NCT06288685 is a Phase 3 clinical trial of percutaneous A1 pulley release in Trigger Finger, sponsored by Police General Hospital, Thailand.

Who is sponsoring NCT06288685?

NCT06288685 is sponsored by Police General Hospital, Thailand.

What drugs are being tested in NCT06288685?

Interventions in NCT06288685: percutaneous A1 pulley release, Triamcinolone.

What condition does NCT06288685 study?

NCT06288685 studies Trigger Finger, Percutaneous A1 Pulley Release, Steroid Injection, Postoperative Pain.

Is NCT06288685 still recruiting?

NCT06288685 is currently completed. Last updated 12 March 2024.

Last reviewed 2024-03-12 · How we verify

NCT06288685

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Percutaneous Trigger Finger Release Concomitant Steroid Injection Versus Percutaneous Trigger Finger Release Alone

Completed Phase 3 Last updated 12 March 2024

What this trial tests

Phase 3 trial testing percutaneous A1 pulley release in Trigger Finger in 38 participants. Completed in 30 January 2024.

Timeline

11 October 2023

Primary endpoint
23 January 2024

30 January 2024

Quick facts

Lead sponsor	Police General Hospital, Thailand
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	38
Start date	11 October 2023
Primary completion	23 January 2024
Estimated completion	30 January 2024
Sites	1 location across Thailand

Drugs / interventions tested

percutaneous A1 pulley release
Triamcinolone (TRIAMCINOLONE) — full drug profile →

Conditions studied

Trigger Finger — all drugs for Trigger Finger →
Percutaneous A1 Pulley Release — all drugs for Percutaneous A1 Pulley Release →
Steroid Injection — all drugs for Steroid Injection →
Postoperative Pain — all drugs for Postoperative Pain →

Sponsor

Police General Hospital, Thailand

Who can join

Adults 18 to 90, any sex, with Trigger Finger or Percutaneous A1 Pulley Release. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Percutaneous A1 pulley release is a cost-effective and straightforward procedure with outcomes comparable to open A1 pulley release. Postoperative pain is a prevalent concern. Corticosteroid injection is a common nonoperative treatment for trigger finger, providing favorable outcomes but associated with a notable risk of recurrence. Numerous studies have explored the combined approach of percutaneous trigger finger release with corticosteroid injection. However, to date, there is no report on early postoperative results. Objective: To conduct a comparative analysis of early postoperative outcomes between percutaneous A1 pulley release with steroid injection and percutaneous A1 pulley release alone. Study Design \& Methods: This study constitutes a randomized controlled trial involving patients with trigger finger who underwent percutaneous release surgery from October 2023 to January 2024. A total of 38 patients were enrolled, with 18 assigned to the percutaneous A1 pulley release with steroid injection group and 20 to the percutaneous A1 pulley release alone group. Postoperative assessments included pain scores using the Visual Analog Scale (VAS), evaluation of quality of life through the QuickDASH score (qDASH), patient satisfaction, and complications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Trigger Finger

Currently open trials in the same condition.

NCT07516652 — Prospective Randomized Trial Comparing Longitudinal vs. Transverse A1 Pulley Release · NA · recruiting
NCT07256522 — Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger · NA · recruiting
NCT06788860 — Efficacy of Ultrasound-Guided Needle Knife Release for Trigger Finger · NA · recruiting
NCT05837286 — Conservative Treatment of Trigger Finger · NA · recruiting
NCT05045157 — Effectiveness of Percutaneous Pulley Release With Infiltration, Versus Infiltration Alone in Trigger Finders · NA · recruiting

Other Police General Hospital, Thailand trials

Trials by the same sponsor.

NCT06262932 — Effectiveness of Repeated Amiodarone Dosing Regimen Versus Standard Dosing Regimen in Atrial Fibrillation Patient With R · Phase 4 · completed
NCT06275828 — The Effect of Perioperative and Postoperative Music Reduces Pain Perception After Anterior Cruciate Ligament Reconstruct · NA · unknown
NCT06239038 — Does Electrocautery Increase Postoperative Pain in Primary Total Knee Arthroplasty · Phase 3 · unknown
NCT06260761 — MIPO Versus Conventional Approach in Volar Locking Plate for Close Fractures Distal End Radius Under WALANT · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06288685 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Police General Hospital, Thailand
Last refreshed: 12 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06288685.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing